Perfil
Carl Damiani served as the President and Chief Operating Officer of Transition Therapeutics, Inc. from 2015 to 2016.
Prior to that, he held positions at the same company from 2003 to 2016.
Antiguos cargos conocidos de Carl Damiani.
| Empresas | Cargo | Fin |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Presidente | 01/12/2016 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Carl Damiani
